Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Will This Slumping Health Stock Rebound in 2014?

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

It's hard to find a more disappointing stock in the medical device world this year than Edwards Lifesciences (NYSE: EW  ) . This innovative company has rallied behind its Sapien transcatheter heart valve, but Edwards's stock hasn't impressed anyone in 2013: Shares have fallen more than 18% this year to date, even as the stock has recovered some of its losses in 2014.

Competition's breathing down Edwards' throat, even as the company protects its first-mover advantage in the U.S. Edwards won a big injunction in Germany against rival Medtronic (NYSE: MDT  ) and its competing CoreValve, but Medtronic's still pushing ahead in this growing market. Meanwhile, Boston Scientific (NYSE: BSX  ) and St. Jude Medical (NYSE: STJ  ) are moving in on the Sapien with rival products of their own.

Can Edwards hold off the competition in order to establish the Sapien's dominance in the U.S., Japan, and other top markets? In the video below, Motley Fool contributor Dan Carroll tells you what you need to know about this innovative company's flagship product-and whether or not the Sapien can help Edwards's stock bounce back for investors.

Beefing up your portfolio's growth
One of the best ways to unlock your best growth opportunities in health care is to find companies like Edwards that shun the status quo and instead discover revolutionary, groundbreaking technologies. In the Motley Fool's brand-new FREE report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2679763, ~/Articles/ArticleHandler.aspx, 9/29/2016 1:35:10 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 3 hours ago Sponsored by:
DOW 18,339.24 110.94 0.61%
S&P 500 2,171.37 11.44 0.53%
NASD 5,318.55 12.84 0.24%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 4:02 PM
EW $120.46 Down -0.76 -0.63%
Edwards Lifescienc… CAPS Rating: ****
BSX $23.75 Up +0.03 +0.13%
Boston Scientific CAPS Rating: ***
MDT $86.74 Up +0.07 +0.08%
Medtronic CAPS Rating: *****
STJ $79.73 Up +0.13 +0.16%
St. Jude Medical CAPS Rating: **